Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Thielemans, K' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 85 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ten Bosch, JV; Otten, J; Thielemans, K
      Autoimmune Lymphoproliferative Syndrome type III, an indefinite disorder

      LEUKEMIA & LYMPHOMA
    2. ten Bosch, JV; Otten, J; Thielemans, K
      Autoimmune lymphoproliferative syndrome type III: An indefinite disorder

      LEUKEMIA & LYMPHOMA
    3. Bakkus, MHC; Asosingh, K; Vanderkerken, K; Thielemans, K; Hagemeijer, A; De Raeve, H; Van Camp, B
      Myeloma isotype-switch variants in the murine 5T myeloma model: evidence that myeloma IgM and IgA expressing subclones can originate from the IgG expressing tumour

      LEUKEMIA
    4. Bullens, DMA; Kasran, A; Thielemans, K; Bakkus, M; Ceuppens, JL
      CD40L-Induced IL-12 production is further enhanced by the Th2 cytokines IL-4 and IL-13

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    5. Bakkus, MHC; Schots, R; La Fuente, PBG; Van Riet, I; Thielemans, K; De Waele, M; Van Camp, B
      Clonally related IgA- and IgE-secreting plasma cells in a myeloma patient

      EUROPEAN JOURNAL OF HAEMATOLOGY
    6. Gancberg, D; Zeicher, M; Bakkus, M; Dupont, F; Leo, O; Moser, M; Spegelaere, P; Thielemans, K; Urbain, J; Horth, M
      Oncoselective transduction of CD80 and CD86 in tumor cell lines using an autonomous recombinant parvovirus

      ANTICANCER RESEARCH
    7. Jacobson, M; Levkovitz, R; Ben-Tal, A; Thielemans, K; Spinks, T; Belluzzo, D; Pagani, E; Bettinardi, V; Gilardi, MC; Zverovich, A; Mitra, G
      Enhanced 3D PET OSEM reconstruction using inter-update Metz filtering

      PHYSICS IN MEDICINE AND BIOLOGY
    8. Moulin, V; Andris, F; Thielemans, K; Maliszewski, C; Urbain, J; Moser, M
      B lymphocytes regulate dendritic cell (DC) function in vivo: Increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation

      JOURNAL OF EXPERIMENTAL MEDICINE
    9. Van Ginderachter, JA; Liu, YQ; Geldhof, AB; Brijs, L; Thielemans, K; De Baetselier, P; Raes, G
      B7-1, IFN gamma and anti-CTLA-4 co-operate to prevent T-cell tolerization during immunotherapy against a murine T-lymphoma

      INTERNATIONAL JOURNAL OF CANCER
    10. Schultz, ES; Lethe, B; Cambiaso, CL; Van Snick, J; Chaux, P; Corthals, J; Heirman, C; Thielemans, K; Boon, T; van der Bruggen, P
      A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4(+) cytolytic T lymphocytes

      CANCER RESEARCH
    11. Jacquemin, M; Benhida, A; Peerlinck, K; Desqueper, B; Elst, LV; Lavend'homme, R; d'Oiron, R; Schwaab, R; Bakkus, M; Thielemans, K; Gilles, JG; Vermylen, J; Saint-Remy, JM
      A human antibody directed to the factor VIIIC1 domain inhibits factor VIIIcofactor activity and binding to von Willebrand factor

      BLOOD
    12. Zhou, L; Ismaili, J; Stordeur, P; Thielemans, K; Goldman, M; Pradier, O
      Inhibition of the CD40 pathway of monocyte activation by triazolopyrimidine

      CLINICAL IMMUNOLOGY
    13. Bartholome, EJ; Willems, F; Crusiaux, A; Thielemans, K; Schandene, L; Goldman, M
      IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: Selective inhibition of CD40-dependent interleukin-12 secretion

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    14. Selmayr, M; Strehl, J; Kremer, JP; Kremmer, E; Doenecke, A; Hallek, M; Menzel, H; Thielemans, K; Thierfelder, S; Mocikat, R
      Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype

      GENE THERAPY
    15. Maldonado-Lopez, R; De Smedt, T; Pajak, B; Heirman, C; Thielemans, K; Leo, O; Urbain, J; Maliszewski, CR; Moser, M
      Role of CD8 alpha(+) and CD8 alpha(-) dendritic cells in the induction of primary immune responses in vivo

      JOURNAL OF LEUKOCYTE BIOLOGY
    16. Bartholome, EJ; Willems, F; Crusiaux, A; Thielemans, K; Schandene, L; Goldman, M
      Interferon-beta inhibits Th1 responses at the dendritic cell level - Relevance to multiple sclerosis

      ACTA NEUROLOGICA BELGICA
    17. Kwak, LW; Thielemans, K; Massaia, M
      Idiotypic vaccination as therapy for multiple myeloma

      SEMINARS IN HEMATOLOGY
    18. De Veerman, M; Heirman, C; Van Meirvenne, S; Devos, S; Corthals, J; Moser, M; Thielemans, K
      Retrovirally transduced bone marrow-derived dendritic cells require CD4(+)T cell help to elicit protective and therapeutic antitumor immunity

      JOURNAL OF IMMUNOLOGY
    19. Chaux, P; Vantomme, V; Stroobant, V; Thielemans, K; Corthals, J; Luiten, R; Eggermont, AMM; Boon, T; van der Bruggen, P
      Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

      JOURNAL OF EXPERIMENTAL MEDICINE
    20. Maldonado-Lopez, R; De Smedt, T; Michel, P; Godfroid, J; Pajak, B; Heirman, C; Thielemans, K; Leo, O; Urbain, J; Moser, M
      CD8 alpha(+) and CD8 alpha(-) subclasses of dendritic cells direct the development of distinct T helper cells in vivo

      JOURNAL OF EXPERIMENTAL MEDICINE
    21. Hallez, S; Detremmerie, O; Giannouli, C; Thielemans, K; Gajewski, TF; Burny, A; Leo, O
      Interleukin-12-secreting human papillomavirus type 16-transformed cells provide a potent cancer vaccine that generates E7-directed immunity

      INTERNATIONAL JOURNAL OF CANCER
    22. Chaussabel, D; Jacobs, F; de Jonge, A; de Veerman, M; Carlier, Y; Thielemans, K; Goldman, M; Vray, B
      CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation

      INFECTION AND IMMUNITY
    23. Lambrecht, BN; Germonpre, PR; Everaert, EG; Carro-Muino, I; De Veerman, M; de Felipe, C; Hunt, SP; Thielemans, K; Joos, GF; Pauwels, RA
      Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation

      EUROPEAN JOURNAL OF IMMUNOLOGY
    24. Vanham, G; Penne, L; Devalck, J; Kestens, L; Colebunders, R; Bosmans, E; Thielemans, K; Ceuppens, JL
      Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    25. Noppe, SM; Heirman, C; Bakkus, MHC; Brissinck, J; Schots, R; Thielemans, K
      The genetic variability of the V-H genes in follicular lymphoma: the impact of the hypermutation mechanism

      BRITISH JOURNAL OF HAEMATOLOGY
    26. ten Bosch, JVD; Delabie, J; Bohler, T; Verschuere, J; Thielemans, K
      Revision of the diagnosis of T-zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II

      BRITISH JOURNAL OF HAEMATOLOGY
    27. Cooke, F; Bakkus, M; Thielemans, K; Pico, JL; Apperley, JF; Samson, D
      Use of quantitative ASO-PCR to predict relapse in multiple myeloma

      BRITISH JOURNAL OF HAEMATOLOGY
    28. van Baren, N; Brasseur, F; Godelaine, D; Hames, G; Ferrant, A; Lehmann, F; Andre, M; Ravoet, C; Doyen, C; Spagnoli, GC; Bakkus, M; Thielemans, K; Boon, T
      Genes encoding tumor-specific antigens are expressed in human myeloma cells

      BLOOD
    29. MALDONADO F; DESMET T; THIELEMANS K; URBAIN J; LEO O; MOSER M
      CD8-ALPHA(-ALPHA(-) DC INDUCE THE DEVELOPMENT OF DISTINCT T-HELPER SUBSETS IN-VIVO() AND CD8)

      Journal of leukocyte biology
    30. RAES G; VANGINDERACHTER J; LIU YQ; BRYS L; THIELEMANS K; DEBAETSELIER P; GELDHOF A
      ACTIVE ANTITUMOR IMMUNOTHERAPY, WITH OR WITHOUT B7-MEDIATED COSTIMULATION, INCREASES TUMOR PROGRESSION IN AN IMMUNOGENIC MURINE T-CELL LYMPHOMA MODEL

      Cancer immunology and immunotherapy
    31. ZHOU L; STORDEUR P; DELAVAREILLE A; THIELEMANS K; CAPEL P; GOLDMAN M; PRADIER O
      CD40 ENGAGEMENT ON ENDOTHELIAL-CELLS PROMOTES TISSUE FACTOR-DEPENDENTPROCOAGULANT ACTIVITY

      Thrombosis and haemostasis
    32. VANRIET I; JUGE N; FACON T; DEWAELE M; SCHOTS R; THIELEMANS K; VANCAMP B; BAKKUS M
      EX-VIVO EXPANSION OF MOBILIZED CD34-CELLS IN MULTIPLE-MYELOMA AND ITSIMPLICATION FOR THE GROWTH SUPPORT OF RESIDUAL TUMOR-CELLS IN THE AUTOGRAFT( BLOOD)

      Bone marrow transplantation
    33. PLANKEN EV; VANDEVELDE H; FALKENBURG JHF; THIELEMANS K; WILLEMZE R; KLUINNELEMANS JC
      SELECTIVE RESPONSE OF CD5(-CELL MALIGNANCIES TO ACTIVATION OF THE CD72 ANTIGEN() B)

      Clinical immunology and immunopathology
    34. CAVE H; TENBOSCH JV; SUCIU S; GUIDAL C; WATERKEYN C; OTTEN J; BAKKUS M; THIELEMANS K; GRANDCHAMP B; VILMER E
      CLINICAL-SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA

      The New England journal of medicine
    35. DEJONGE J; HEIRMAN C; DEVEERMAN M; VANMEIRVENNE S; MOSER M; LEO O; THIELEMANS K
      IN-VIVO RETARGETING OF T-CELL EFFECTOR FUNCTION BY RECOMBINANT BISPECIFIC SINGLE-CHAIN FV (ANTI-CD3 X ANTIIDIOTYPE) INDUCES LONG-TERM SURVIVAL IN THE MURINE BCL1 LYMPHOMA MODEL

      The Journal of immunology (1950)
    36. LESPAGNARD L; METTENS P; VERHEYDEN AM; TASIAUX N; THIELEMANS K; VANMEIRVENNE S; GELDHOF A; DEBAETSELIER P; URBAIN J; LEO O; MOSER M
      DENDRITIC CELLS FUSED WITH MASTOCYTOMA-CELLS ELICIT THERAPEUTIC ANTITUMOR IMMUNITY

      International journal of cancer
    37. FONTT EO; DEBAETSELIER P; HEIRMAN C; THIELEMANS K; LUCAS R; VRAY B
      EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND TUMOR-NECROSIS-FACTOR-ALPHA ON TRYPANOSOMA-CRUZI TRYPOMASTIGOTES

      Infection and immunity
    38. ZHU D; VANARKEL C; KING CA; VANMEIRVENNE S; DEGREEF C; THIELEMANS K; RADL J; STEVENSON FK
      IMMUNOGLOBULIN V-H GENE SEQUENCE-ANALYSIS OF SPONTANEOUS MURINE IMMUNOGLOBULINSECRETING B-CELL TUMORS WITH CLINICAL-FEATURES OF HUMAN-DISEASE

      Immunology
    39. DONCKIER V; FLAMAND V; DESALLE F; VANDERHAEGHEN ML; DEVEERMAN M; THIELEMANS K; ABRAMOWICZ D; GOLDMAN M
      IL-12 PREVENTS NEONATAL INDUCTION OF TRANSPLANTATION TOLERANCE IN MICE

      European Journal of Immunology
    40. TENBOSCH JEV; DEMANET C; BALDUCK N; BAKKUS MHC; DERAEVE H; DESPRECHINS B; OTTEN J; THIELEMANS K
      THE USE OF THE ANTI-MALARIA DRUG FANSIDAR(R) (PYRIMETHAMINE AND SULFADOXINE) IN THE TREATMENT OF A PATIENT WITH AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME AND FAS DEFICIENCY

      British Journal of Haematology
    41. VANBAREN N; BRASSEUR F; HAMES G; GODELAINE D; LANDRY C; FERRANT A; THIELEMANS K; BOON T; COULIE P
      MALIGNANT PLASMA-CELLS EXPRESS GENES OF THE MAGE FAMILY

      British Journal of Haematology
    42. JACQUEMIN MG; DESQUEPER BG; BENHIDA A; VANDERELST L; HOYLAERTS MF; BAKKUS M; THIELEMANS K; ARNOUT J; PEERLINCK K; GILLES JGG; VERMYLEN J; SAINTREMY JMR
      MECHANISM AND KINETICS OF FACTOR-VIII INACTIVATION - STUDY WITH AN IGG4 MONOCLONAL-ANTIBODY DERIVED FROM A HEMOPHILIA-A PATIENT WITH INHIBITOR

      Blood
    43. GELDHOF AB; MOSER M; LESPAGNARD L; THIELEMANS K; DEBAETSELIER P
      INTERLEUKIN-12-ACTIVATED NATURAL-KILLER-CELLS RECOGNIZE B7 COSTIMULATORY MOLECULES ON TUMOR-CELLS AND AUTOLOGOUS DENDRITIC CELLS

      Blood
    44. TOUNGOUZ M; VELU T; THIELEMANS K
      CELLULAR IMMUNOTHERAPY - A NEW AVENUE IN INTERNAL-MEDICINE

      Acta Clinica Belgica
    45. JUGEMORINEAU N; HEIRMAN C; BAKKUS M; VANCAMP B; MALFAIT R; HAROUSSEAU JL; THIELEMANS K; BATAILLE R
      IMMUNOGLOBULIN-D AND IMMUNOGLOBULIN-M MULTIPLE-MYELOMA VARIANTS ARE HEAVILY MUTATED

      Clinical cancer research
    46. VANDENHOVE LE; VANGOOL SW; VANDENBERGHE P; BAKKUS M; THIELEMANS K; BOOGAERTS MA; CEUPPENS JL
      CD40 TRIGGERING OF CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS RESULTS IN EFFICIENT ALLOANTIGEN PRESENTATION AND CYTOTOXIC T-LYMPHOCYTE INDUCTION BY UP-REGULATION OF CD80 AND CD86 COSTIMULATORY MOLECULES

      Leukemia
    47. VANDERKERKEN K; RADL J; VANMEIRVENNE S; DEVEERMAN M; THIELEMANS K; VANCAMP B
      HOMING OF MULTIPLE-MYELOMA CELLS TO THE BONE-MARROW - STUDY IN THE 5TMM MOUSE MODELS

      Experimental hematology
    48. BUELENS C; VERHASSELT V; DEGROOTE D; THIELEMANS K; GOLDMAN M; WILLEMS F
      HUMAN DENDRITIC CELL RESPONSES TO LIPOPOLYSACCHARIDE AND CD40 LIGATION ARE DIFFERENTIALLY REGULATED BY INTERLEUKIN-10

      European Journal of Immunology
    49. BUELENS C; VERHASSELT V; DEGROOTE D; THIELEMANS K; GOLDMAN M; WILLEMS F
      INTERLEUKIN-10 PREVENTS THE GENERATION OF DENDRITIC CELLS FROM HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS CULTURED WITH INTERLEUKIN-4 AND GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR/

      European Journal of Immunology
    50. VANRIET I; JUGEMORINEAU N; SCHOTS R; DEWAELE M; DEGREEF C; THIELEMANS K; VANCAMP B; BAKKUS M
      PERSISTENCE OF RESIDUAL TUMOR-CELLS AFTER CYTOKINE-MEDIATED EX-VIVO EXPANSION OF MOBILIZED CD34(-CELLS IN MULTIPLE-MYELOMA() BLOOD)

      British Journal of Haematology
    51. VANDERKERKEN K; DERAEVE H; GOES E; VANMEIRVENNE S; RADL J; VANRIET I; THIELEMANS K; VANCAMP B
      ORGAN INVOLVEMENT AND PHENOTYPIC ADHESION PROFILE OF 5T2 AND 5T33 MYELOMA CELLS IN THE C57BL KALWRIJ MOUSE/

      British Journal of Cancer
    52. JACQUEMIN MG; DESQUEPER BG; BENHIDA A; VANDERELST L; HOYLAERTS MF; BAKKUS M; THIELEMANS K; ARNOUT J; PEERLINCK K; GILLES JGG; VERMYLEN J; SAINTREMY JMR
      MOLECULAR CHARACTERIZATION OF A FACTOR-VIII SPECIFIC IGG4 MONOCLONAL-ANTIBODY DERIVED FROM A HEMOPHILIA-A PATIENT WITH INHIBITOR

      Blood
    53. FOBELETS K; THIELEMANS K
      OPTICAL MEDIA WITH AN IMAGINARY 3RD-ORDER NONLINEARITY ANALYZED BY HAMILTONIAN-SYSTEMS

      Physical review. A
    54. FONTT EO; HEIRMAN C; THIELEMANS K; VRAY B
      GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GM-CSF) - INVOLVEMENT IN THE CONTROL OF TRYPANOSOMA-CRUZI INFECTION IN MOUSE

      Journal of leukocyte biology
    55. HOLLIGER P; BRISSINCK J; WILLIAMS RL; THIELEMANS K; WINTER G
      SPECIFIC KILLING OF LYMPHOMA-CELLS BY CYTOTOXIC T-CELLS MEDIATED BY ABISPECIFIC DIABODY

      Protein engineering
    56. KRIVONOS S; THIELEMANS K
      A MATHEMATICA(TM) PACKAGE FOR COMPUTING N=2 SUPERFIELD OPERATOR PRODUCT EXPANSIONS

      Classical and quantum gravity
    57. FONTT EO; HEIRMAN C; THIELEMANS K; VRAY B
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - INVOLVEMENT IN CONTROL OF TRYPANOSOMA-CRUZI INFECTION IN MICE

      Infection and immunity
    58. MURAILLE E; DEVOS S; THIELEMANS K; URBAIN J; MOSER M; LEO O
      COSTIMULATION REGULATES THE KINETICS OF INTERLEUKIN-2 RESPONSE TO BACTERIAL SUPERANTIGENS

      Immunology
    59. PRADIER O; WILLEMS F; ABRAMOWICZ D; SCHANDENE L; DEBOER M; THIELEMANS K; CAPEL P; GOLDMAN M
      CD40 ENGAGEMENT INDUCES MONOCYTE PROCOAGULANT ACTIVITY THROUGH AN INTERLEUKIN-10 RESISTANT PATHWAY

      European Journal of Immunology
    60. VANDEVELDE H; THIELEMANS K
      NATIVE SOLUBLE CD5 DELIVERS A COSTIMULATORY SIGNAL TO RESTING HUMAN B-LYMPHOCYTES

      Cellular immunology
    61. JUGEMORINEAU N; BAKKUS M; VANCAMP B; HAROUSSEAU JL; THIELEMANS K; BATAILLE R
      IGD AND IGM MULTIPLE-MYELOMA VARIANTS ARE HEAVILY MUTATED

      Blood
    62. DEMANET C; BRISSINCK J; DEJONGE J; THIELEMANS K
      BISPECIFIC ANTIBODY-MEDIATED IMMUNOTHERAPY OF THE BCL(1) LYMPHOMA - INCREASED EFFICACY WITH MULTIPLE INJECTIONS AND CD28-INDUCED COSTIMULATION

      Blood
    63. BAKKUS MHC; VANRIET I; DEGREEF C; VANCAMP B; THIELEMANS K
      THE CLONOGENIC PRECURSOR CELL IN MULTIPLE-MYELOMA

      Leukemia & lymphoma
    64. MURAILLE E; DEDECKER G; BAKKUS M; THIELEMANS K; URBAIN J; MOSER M; LEO O
      CO-STIMULATION LOWERS THE THRESHOLD FOR ACTIVATION OF NAIVE T-CELLS BY BACTERIAL SUPERANTIGENS

      International immunology
    65. VANGOOL SW; BARCY S; DEVOS S; VANDENBERGHE P; CEUPPENS JL; THIELEMANS K; DEBOER M
      CD80 (B7-1) AND CD86 (B7-2) - POTENTIAL TARGETS FOR IMMUNOTHERAPY

      Research in immunology
    66. DESMEDT T; VANMECHELEN M; ANDRIS F; THIELEMANS K; URBAIN J; MOSER M
      ACTIVATION OF MURINE T-CELLS BY BACTERIAL SUPERANTIGENS REQUIRES B7-MEDIATED COSTIMULATION

      Journal of cellular biochemistry
    67. BOHLEN H; TESCH H; KOCH N; TITZER S; THIELEMANS K; DIEHL V
      IDIOTYPE VACCINATION AGAINST A MURINE B-CELL LYMPHOMA - BOTH DENDRITIC CELLS LOADED WITH IDIOTYPE AND BISPECIFIC IDIOTYPEXANTI-CLASSII ANTIBODIES INDUCE PROTECTIVE IMMUNITY

      Experimental hematology
    68. LU H; WANG XJ; XU KW; POPE CN; THIELEMANS K
      QUANTIZING HIGHER-SPIN STRING THEORIES

      International journal of modern physics A
    69. DEJONGE J; BRISSINCK J; HEIRMAN C; DEMANET C; LEO O; MOSER M; THIELEMANS K
      PRODUCTION AND CHARACTERIZATION OF BISPECIFIC SINGLE-CHAIN ANTIBODY FRAGMENTS

      Molecular immunology
    70. MURAILLE E; DESMEDT T; THIELEMANS K; URBAIN J; MOSER M; LEO O
      ACTIVATION OF MURINE T-CELLS BY BACTERIAL SUPERANTIGENS REQUIRES B7-MEDIATED COSTIMULATION

      Cellular immunology
    71. GELDHOF AB; RAES G; BAKKUS M; DEVOS S; THIELEMANS K; DEBAETSELIER P
      EXPRESSION OF B7-1 BY HIGHLY METASTATIC MOUSE T-LYMPHOMAS INDUCES OPTIMAL NATURAL-KILLER CELL-MEDIATED CYTOTOXICITY

      Cancer research
    72. BAKKUS MHC; LAFUENTE PBG; VANDEVELDE H; VANRIET I; VANCAMP B; THIELEMANS K
      IDENTIFICATION AND EXPANSION OF MULTIPLE-MYELOMA RELATED CELLS EXPRESSING DIFFERENT ISOTYPES - DO THEY BELONG TO THE MALIGNANT CLONE

      Blood
    73. CAVE H; BAKKUS M; SUCIU S; GUIDAL C; FOURNIER M; ROBERT A; BOUTARD P; MECHINAUD F; PLOUVIER E; FERSTER A; NELKEN B; OTTEN J; THIELEMANS K; GRANDCHAMP B; VILMER E
      SIGNIFICANCE OF THE QUANTITATION OF MINIMAL RESIDUAL DISEASE BY PCR AMPLIFICATION OF IGH AND TCR GENE REARRANGEMENTS IN CHILDHOOD ALL - AN EORTC - PROSPECTIVE MULTICENTER STUDY

      Blood
    74. PLANKEN EV; VANDEVELDE H; THIELEMANS K; WILLEMZE R; KLUINNELEMANS JC
      CD5(-CELLS CAN BE ACTIVATED VIA THE CD72 ANTIGEN() MALIGNANT B)

      Blood
    75. SCHOTS R; DEWAELE M; THIELEMANS K; VANRIET I; VANCAMP B; BAKKUS M
      CHARACTERIZATION OF A HUMAN MYELOMA COMPOSED OF 2 DISTINCT, BUT CLONALLY RELATED TUMORAL PLASMA-CELL POPULATIONS THAT SECRETE EITHER IGA ORIGE

      Blood
    76. LU H; POPE CN; WANG XJ; THIELEMANS K
      HIGHER-SPIN STRINGS AND W-MINIMAL MODELS

      Classical and quantum gravity
    77. VANDENDRIESSCHE T; BAKKUS M; TOUSSAINTDEMYLLE D; THIELEMANS K; VERSCHUEREN H; DEBAETSELIER P
      TUMORIGENICITY OF MOUSE T-LYMPHOMA-CELLS IS CONTROLLED BY THE LEVEL OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I H-2K(K) ANTIGENS

      Clinical & experimental metastasis
    78. VANDENDRIESSCHE T; GELDHOF A; BAKKUS M; TOUSSAINTDEMYLLE D; BRIJS L; THIELEMANS K; VERSCHUEREN H; DEBAETSELIER P
      METASTASIS OF MOUSE T-LYMPHOMA-CELLS IS CONTROLLED BY THE LEVEL OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I H-2D(K) ANTIGENS

      International journal of cancer
    79. FLAMAND V; SORNASSE T; THIELEMANS K; DEMANET C; BAKKUS H; BAZIN H; TIELEMANS F; LEO O; URBAIN J; MOSER M
      MURINE DENDRITIC CELLS PULSED IN-VITRO WITH TUMOR-ANTIGEN INDUCE TUMOR RESISTANCE IN-VIVO

      European Journal of Immunology
    80. DEMANET C; BRISSINCK J; LEE O; MOSER M; THIELEMANS K
      ROLE OF T-CELL SUBSETS IN THE BISPECIFIC ANTIBODY (ANTIIDIOTYPE X ANTI-CD3) TREATMENT OF THE BCL(1) LYMPHOMA

      Cancer research
    81. BAKKUS MHC; VANRIET I; VANCAMP B; THIELEMANS K
      EVIDENCE THAT THE CLONOGENIC CELL IN MULTIPLE-MYELOMA ORIGINATES FROMA PRE-SWITCHED BUT SOMATICALLY MUTATED B-CELL

      British Journal of Haematology
    82. VANDEVELDE H; LORRE K; BAKKUS M; THIELEMANS K; CEUPPENS JL; DEBOER M
      CD45RO(-CELLS BUT NOT CD45RA(+) NAIVE T-CELLS CAN BE EFFICIENTLY ACTIVATED BY REMOTE CO-STIMULATION WITH B7() MEMORY T)

      International immunology
    83. SEVRIN A; THIELEMANS K; TROOST W
      RELATION BETWEEN LINEAR AND NONLINEAR N = 3,4 SUPERGRAVITY THEORIES

      Physical review. D. Particles and fields
    84. SEVRIN A; THIELEMANS K; TROOST W
      INDUCED AND EFFECTIVE GRAVITY THEORIES IN D=2

      Nuclear physics. B
    85. THIELEMANS K
      NEW STRATEGIES FOR THERAPEUTIC INTERVENTION IN B-CELL MALIGNANCIES

      Experimental hematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 05:51:18